1
|
Altschuck N, van Munster M, Stümpel J, Pedrosa DJ, Wellach I, Boebinger H, Geraedts M. Mixed-methods process evaluation of a proactive approach to healthcare in Parkinson's disease-ParkProReakt: a protocol of a hybrid efficacy-implementation study. BMJ Neurol Open 2024; 6:e000966. [PMID: 39737345 PMCID: PMC11683930 DOI: 10.1136/bmjno-2024-000966] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2024] [Accepted: 12/07/2024] [Indexed: 01/01/2025] Open
Abstract
ABSTRACT Introduction People with Parkinson's disease (PwPD) experience a wide range of motor and non-motor symptoms that have a significant impact on their health and quality of life. Effective care management for PwPD involves monitoring symptoms at home, involving specialised multidisciplinary care providers and enhancing self-management skills. This study protocol describes the process evaluation within a randomised clinical trial to assess the implementation and its impact on patient health outcomes of ParkProReakt-a proactive, multidisciplinary, digitally supported care model for community-dwelling PwPD. Methods and analysis The hybrid efficacy-implementation study will assess key implementation outcomes using the Medical Research Council framework for complex interventions alongside a randomised controlled trial. A combination of quantitative and qualitative methods will be used to assess process data from care providers and patients. The main process outcomes are fidelity, dose, feasibility and context. Context will be analysed through semistructured interviews and focus groups using the Consolidated Framework of Implementation Research. To elucidate potential facilitators and barriers to implementation and to gain deeper insights into the efficacy outcome data, quantitative and qualitative process data will be integrated at an interpretative level using mixed methods. In addition to process evaluation, potential indirect mechanisms of impact will be measured. Ethics and dissemination Ethical approval for this study was obtained from the responsible state medical ethics committees in Hesse and Hamburg, Germany. Results will be communicated to the funding body and disseminated through scientific publications. Trial registration This study was registered with the German Registry for Clinical Studies (DRKS)-number: DRKS00031092.
Collapse
Affiliation(s)
- Natalie Altschuck
- Institute for Health Services Research and Clinical Epidemiology, Philipps University Marburg, Marburg, Germany
- Department of Health Sciences, Fulda University of Applied Sciences, Fulda, Germany
| | - Marlena van Munster
- Department of Neurology, Philipps University Marburg, Marburg, Germany
- Department of International Health, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands
- Working Group Health Policy and Systems Research and Innovation, Institute for General Practice, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Johanne Stümpel
- Department of Neurology, Philipps University Marburg, Marburg, Germany
- Center for Life Ethics, University of Bonn, Bonn, Germany
| | - David Jose Pedrosa
- Department of Neurology, University Hospital of Giessen and Marburg Campus Marburg, Marburg, Germany
- Center for Mind, Brain and Behaviour (CMBB), Philipps University Marburg, Marburg, Germany
| | - Ingmar Wellach
- Praxis für Neurologie und Psychiatrie Hamburg Walddörfer, Hamburg, Germany
| | - Hannes Boebinger
- Innovationsfonds & Produktportfolio, Techniker Krankenkasse, Hamburg, Germany
| | - Max Geraedts
- Institute for Health Services Research and Clinical Epidemiology, Philipps University Marburg, Marburg, Germany
| |
Collapse
|
2
|
Pirtošek Z. Breaking barriers in Parkinson's care: the multidisciplinary team approach. J Neural Transm (Vienna) 2024; 131:1349-1361. [PMID: 39417880 PMCID: PMC11502601 DOI: 10.1007/s00702-024-02843-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2024] [Accepted: 10/01/2024] [Indexed: 10/19/2024]
Abstract
Parkinson's disease is a complex neurodegenerative disorder presenting a range of motor and non-motor symptoms that greatly impact both patients and caregivers. The diverse needs arising from these symptoms make a multidisciplinary team (MDT) approach crucial for effective management. This article explores the role and benefits of MDTs in Parkinson's care, highlighting how collaborative models improve clinical outcomes and quality of life. MDTs integrate neurologists, nurse specialists, therapists, and other professionals to deliver comprehensive, patient-centered care. The inclusion of patients and caregivers fosters shared decision-making, enhancing health outcomes. However, challenges like limited controlled trials, lack of comprehensive guidelines, and under-referral remain. Innovative models, such as telehealth and community-based care, offer promising solutions, especially in underserved regions. The article advocates for further research and standardized guidelines to optimize the MDT approach for Parkinson's disease.
Collapse
Affiliation(s)
- Zvezdan Pirtošek
- Department of Neurology University Medical Centre, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
| |
Collapse
|
3
|
Hanskamp-Sebregts M, van Gurp PJ, Braspenning J. Design and Validation of a Questionnaire to Measure Interprofessional Collaborative Practice for Auditing Integrated Hospital Care: Empirical Research. THE JOURNAL OF CONTINUING EDUCATION IN THE HEALTH PROFESSIONS 2024; 44:171-179. [PMID: 38015499 PMCID: PMC11338029 DOI: 10.1097/ceh.0000000000000544] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/29/2023]
Abstract
INTRODUCTION Interprofessional teamwork is the key issue of delivering integrated hospital care; however, measuring interprofessional collaboration for auditing is fragmented. In this study, a questionnaire to measure InterProfessional collaborative Practice for Integrated Hospital care (IPPIH) has been developed and validated. METHODS A four-step iterative process was conducted: (1) literature search to find suitable questionnaires; (2) semistructured stakeholder interviews (individual and in focus groups) to discuss the topics and questions (face validity), (3) pretesting the prototype of the questionnaire in two different integrated care pathways for feasibility, usability, and internal consistency, and (4) testing (content and construct validity and responsiveness) of the revised questionnaire in eight integrated care pathways; the validation and responsiveness was tested by means of exploratory factor analysis, calculation of Cronbach alpha, item analysis, and linear mixed model analysis. RESULTS Based on six questionnaires and the opinion of direct stakeholders, the questionnaire IPPIH comprised 27 items. Five different domains could be distinguished: own skills, culture, coordination and collaboration, practical support, and appreciation with the Cronbach alpha varied from 0.91 to 0.48. The self-reported intensity of the collaboration within a specific care pathway significantly influenced the outcome ( P = .000). DISCUSSION The product is a questionnaire, IPPIH, which can measure the degree of interprofessional collaborative practice in integrated hospital care pathways. The IPPIH was initially developed for quality assurance. However, the IPPIH also seems to be suitable as a self-assessment tool for directors to monitor and improve the interprofessional collaboration and the quality of their integrated care pathway.
Collapse
Affiliation(s)
- Mirelle Hanskamp-Sebregts
- Dr. Hanskamp-Sebregts: Radboud University Medical Center, Institute of Quality Assurance and Patient Safety, Nijmegen, The Netherlands. Prof. van Gurp: Radboud University Medical Center, Institute of Quality Assurance and Patient Safety, Nijmegen, The Netherlands, and Department of General Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. Prof. Braspenning: IQ Healthcare, Radboud Institute of Health Sciences, Nijmegen, The Netherlands
| | - Petra J. van Gurp
- Dr. Hanskamp-Sebregts: Radboud University Medical Center, Institute of Quality Assurance and Patient Safety, Nijmegen, The Netherlands. Prof. van Gurp: Radboud University Medical Center, Institute of Quality Assurance and Patient Safety, Nijmegen, The Netherlands, and Department of General Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. Prof. Braspenning: IQ Healthcare, Radboud Institute of Health Sciences, Nijmegen, The Netherlands
| | - Jozé Braspenning
- Dr. Hanskamp-Sebregts: Radboud University Medical Center, Institute of Quality Assurance and Patient Safety, Nijmegen, The Netherlands. Prof. van Gurp: Radboud University Medical Center, Institute of Quality Assurance and Patient Safety, Nijmegen, The Netherlands, and Department of General Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. Prof. Braspenning: IQ Healthcare, Radboud Institute of Health Sciences, Nijmegen, The Netherlands
| |
Collapse
|
4
|
Okun MS. U.S. Tax Credits to Promote Practical Proactive Preventative Care for Parkinson's Disease. JOURNAL OF PARKINSON'S DISEASE 2024; 14:221-226. [PMID: 38457153 PMCID: PMC10977447 DOI: 10.3233/jpd-240046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 02/08/2024] [Indexed: 03/09/2024]
Abstract
Persons with Parkinson's disease (PD) and society at large can profit from a strategic investment into a forward leaning, practical, preventative, and proactive multidisciplinary care policy. The American healthcare system is not easily bent to accommodate this type of care, and thus a tax benefit is an attractive option. An individual federal income tax benefit of $6200 each year for every person residing in the US with a diagnosis of PD, could among other offerings provide monthly access to a licensed clinical social worker and access to mental health services. The implementation of more coordinated care has the potential reduce the burden of depression, anxiety, and demoralization. Personal training would also be covered and directed by physical and occupational therapists. The combination of home-based and telemedicine services would have the added benefit of improving access. The tax benefit would also provide access to a dietician. This type of care strategy could be designed to proactively identify early signs of aspiration and urinary tract infections to 'head off' significant morbidity. A $6200/year individual tax benefit for those diagnosed with PD will thus translate into more fall prevention, more care in the home setting, less hospitalizations, less depression, less anxiety, less demoralization, better diets, and less persons placed in nursing facilities. Additionally, this tax benefit will provide the potential for billions of dollars in savings to the healthcare system. A tax benefit for PD is a practical preventative and proactive strategy which can serve to advantage both this generation and the next.
Collapse
Affiliation(s)
- Michael S. Okun
- Department of Neurology, Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, USA
| |
Collapse
|
5
|
Saatchi AG, Pallotti F, Sullivan P. Network approaches and interventions in healthcare settings: A systematic scoping review. PLoS One 2023; 18:e0282050. [PMID: 36821554 PMCID: PMC9949682 DOI: 10.1371/journal.pone.0282050] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2022] [Accepted: 02/07/2023] [Indexed: 02/24/2023] Open
Abstract
INTRODUCTION The growing interest in networks of interactions is sustained by the conviction that they can be leveraged to improve the quality and efficiency of healthcare delivery systems. Evidence in support of this conviction, however, is mostly based on descriptive studies. Systematic evaluation of the outcomes of network interventions in healthcare settings is still wanting. Despite the proliferation of studies based on Social Network Analysis (SNA) tools and techniques, we still know little about how intervention programs aimed at altering existing patterns of social interaction among healthcare providers affect the quality of service delivery. We update and extend prior reviews by providing a comprehensive assessment of available evidence. METHODS AND FINDINGS We searched eight databases to identify papers using SNA in healthcare settings published between 1st January 2010 and 1st May 2022. We followed Chambers et al.'s (2012) approach, using a Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist. We distinguished between studies relying on SNA as part of an intervention program, and studies using SNA for descriptive purposes only. We further distinguished studies recommending a possible SNA-based intervention. We restricted our focus on SNA performed on networks among healthcare professionals (e.g., doctors, nurses, etc.) in any healthcare setting (e.g., hospitals, primary care, etc.). Our final review included 102 papers. The majority of the papers used SNA for descriptive purposes only. Only four studies adopted SNA as an intervention tool, and measured outcome variables. CONCLUSIONS We found little evidence for SNA-based intervention programs in healthcare settings. We discuss the reasons and challenges, and identify the main component elements of a network intervention plan. Future research should seek to evaluate the long-term role of SNA in changing practices, policies and behaviors, and provide evidence of how these changes affect patients and the quality of service delivery.
Collapse
Affiliation(s)
| | - Francesca Pallotti
- Department of Business, Operations and Strategy, University of Greenwich, London, United Kingdom
| | - Paul Sullivan
- NIHR ARC Northwest London, Imperial College London, London, United Kingdom
- University Sussex Hospitals NHS Foundation Trust, Sussex, United Kingdom
| |
Collapse
|
6
|
Tosin MHS, Mecone CAC, Oliveira EFM, Tsui DS, Tan SB, Irene S, Oliveira BC, de Oliveira BGRB. Nursing and Parkinson's Disease: A Scoping Review of Worldwide Studies. Clin Nurs Res 2022; 31:230-238. [PMID: 34486425 DOI: 10.1177/10547738211044047] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
This scoping review aims to evaluate the characteristics of worldwide studies evolving the scope of nursing practice in Parkinson's disease (PD). We conducted a three-step search strategy using 11 databases and reference lists. Of the 4,174 screened studies we included 324 (8%). Most were published during 1978 to 2020, with significant increasing in publications from 2002 onwards and a forecast to double in the next 10 years (total expected = 614, ±62.2, R2 = .998). We identified studies involving nine contexts of nursing practice in PD, in four continents and 31 countries, most of them of observational design (47.2%), funded (52.2%), authored by nurses (70.1%), and related to Nursing care/Guidelines (32.1%), Educational/Research content (16.4%), Symptom management/Medication adherence (14.5%), and Family caregiving (11.1%). The worldwide studies evolving the scope of nursing practice in PD is growing in several health context. These results can guide future research and evidence-based practice involving the role of nurses in PD.
Collapse
Affiliation(s)
- Michelle Hyczy S Tosin
- Fluminense Federal University, Niterói, Rio de Janeiro, Brazil
- Rush University Medical Center, Chicago, IL, USA
| | | | | | | | | | - Sin Irene
- Singapore General Hospital, Singapore
| | | | | |
Collapse
|
7
|
Kerkemeyer L, Claus I, Kutscher M, von Stülpnagel V, Zur Nieden P, Huchtemann T, Warnecke T. Strengthening Communication and Collaboration in the Fragmented German Healthcare System: A Mixed-Method Evaluation of an Interdisciplinary Network for Parkinson's Disease. JOURNAL OF PARKINSON'S DISEASE 2022; 12:1307-1317. [PMID: 35253779 DOI: 10.3233/jpd-213072] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
BACKGROUND To improve Parkinson's disease (PD) care, interdisciplinary and patient-centered treatment is mandatory. A key problem in many healthcare systems is the limited and unspecific communication among different healthcare professionals. Optimal collaboration between various professionals involved is indispensable. Parkinson's Network Münsterland + (PNM +) is an interdisciplinary network of medical and non-medical experts involved in the treatment of PD patients in Germany. OBJECTIVE The aim of this evaluation was to analyze the network structures of PNM+ as well as communication and collaboration between PNM + partners. METHODS A mixed methods approach was applied consisting of a social network analysis, a validated questionnaire on team effectiveness and semi-structured interviews focusing on perceived barriers and supportive aspects of PNM + . RESULTS Quantitative and qualitative data suggested increased collaboration between professionals within PNM + . The reciprocity of connections was 0.522 in the network of professional contacts. Regular exchanges in terms of interdisciplinary panel meetings and working groups stimulated knowledge transfer, leading to greater specialization of general neurologists and therapists in PD. The progressive density of the network from 0.136 to 0.279 illustrates the growing cooperation of PNM + partners. Interviewed partners requested more patient-specific collaboration but expected this to happen as the network evolved. Overall, PNM + has already improved both diagnosis and therapy thanks to knowledge transfer. Structured treatment recommendations helped to improve communication between healthcare professionals. CONCLUSION PNM+ stimulated exchange between different healthcare professionals involved in the treatment of PD patients. This overcomes specific barriers within Germany's highly fragmented healthcare system, such as the lack of communication between these disciplines.
Collapse
Affiliation(s)
- Linda Kerkemeyer
- Institute for Applied Health Services Research (inav), Berlin, Germany
| | - Inga Claus
- Department of Neurology, University of Münster, Münster, Germany
| | - Michelle Kutscher
- Institute for Applied Health Services Research (inav), Berlin, Germany
| | | | | | - Tessa Huchtemann
- Department of Neurology, University of Münster, Münster, Germany
| | - Tobias Warnecke
- Department of Neurology, University of Münster, Münster, Germany
- Department of Neurology and Neurorehabilitation, Klinikum Osnabrück, University of Münster, Osnabrück, Germany
| |
Collapse
|
8
|
van Munster M, Stümpel J, Thieken F, J. Pedrosa D, Antonini A, Côté D, Fabbri M, Ferreira JJ, Růžička E, Grimes D, Mestre TA. Moving towards Integrated and Personalized Care in Parkinson's Disease: A Framework Proposal for Training Parkinson Nurses. J Pers Med 2021; 11:623. [PMID: 34209024 PMCID: PMC8304750 DOI: 10.3390/jpm11070623] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2021] [Revised: 06/17/2021] [Accepted: 06/25/2021] [Indexed: 12/28/2022] Open
Abstract
Delivering healthcare to people living with Parkinson's disease (PD) may be challenging in face of differentiated care needs during a PD journey and a growing complexity. In this regard, integrative care models may foster flexible solutions on patients' care needs whereas Parkinson Nurses (PN) may be pivotal facilitators. However, at present hardly any training opportunities tailored to the care priorities of PD-patients are to be found for nurses. Following a conceptual approach, this article aims at setting a framework for training PN by reviewing existing literature on care priorities for PD. As a result, six prerequisites were formulated concerning a framework for training PN. The proposed training framework consist of three modules covering topics of PD: (i) comprehensive care, (ii) self-management support and (iii) health coaching. A fourth module on telemedicine may be added if applicable. The framework streamlines important theoretical concepts of professional PD management and may enable the development of novel, personalized care approaches.
Collapse
Affiliation(s)
- Marlena van Munster
- Department of Neurology, University Hospital Marburg, 35033 Marburg, Germany; (F.T.); (D.J.P.)
| | - Johanne Stümpel
- Cologne Center for Ethics, Rights, Economics, and Social Sciences of Health (CERES), University of Cologne, 50931 Cologne, Germany;
- Research Unit Ethics, University Hospital Cologne, 50931 Cologne, Germany
| | - Franziska Thieken
- Department of Neurology, University Hospital Marburg, 35033 Marburg, Germany; (F.T.); (D.J.P.)
| | - David J. Pedrosa
- Department of Neurology, University Hospital Marburg, 35033 Marburg, Germany; (F.T.); (D.J.P.)
| | - Angelo Antonini
- Parkinson and Movement Disorders Unit, University of Padua, 35122 Padua, Italy;
| | - Diane Côté
- The Ottawa Hospital Research Institute, Ottawa, ON K1Y 4E9, Canada;
| | - Margherita Fabbri
- Department of Neurosciences, Clinical Investigation Center CIC 1436, Parkinson Toulouse Expert Center, NS-Park/FCRIN Network and NeuroToul COEN Center, TOULOUSE University Hospital, INSERM, University of Toulouse 3, 31062 Toulouse, France;
| | - Joaquim J. Ferreira
- Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal;
- Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal
- CNS—Campus Neurológico Sénior Torres Vedras, 2560-280 Torres Vedras, Portugal
| | - Evžen Růžička
- Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University, General University Hospital in Prague, CZ-121 08 Prague, Czech Republic;
| | - David Grimes
- Parkinson Disease and Movement Disorders Centre, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa Brain and Mind Research Institute, Ottawa, ON K1Y 4E9, Canada; (D.G.); (T.A.M.)
| | - Tiago A. Mestre
- Parkinson Disease and Movement Disorders Centre, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa Brain and Mind Research Institute, Ottawa, ON K1Y 4E9, Canada; (D.G.); (T.A.M.)
| |
Collapse
|
9
|
Bloem BR, Eimers M, van Galen MS, Munneke M, Darweesh SKL. From trials to clinical practice: Temporal trends in the coverage of specialized allied health services for Parkinson's disease. Eur J Neurol 2020; 28:775-782. [PMID: 33141474 DOI: 10.1111/ene.14627] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2020] [Revised: 10/17/2020] [Accepted: 10/29/2020] [Indexed: 12/25/2022]
Abstract
BACKGROUND AND PURPOSE To determine how the coverage of specialized allied health services for patients with Parkinson's disease (PD) has developed in the Netherlands since the publication of trials that demonstrated cost-effectiveness. METHODS We used healthcare expenditure-based data on all insured individuals in the Netherlands to determine the annual proportion of patients with PD who received either specialized or generic allied health services (physiotherapy, occupational therapy, speech-language therapy) in 2 calendar years separated by a 5-year interval (2012 and 2017). Specialized allied health services were delivered through the ParkinsonNet approach, which encompassed professional training and concentration of care among specifically trained professionals. RESULTS Between 2012 and 2017, there was an increase in the number of patients with any physiotherapy (from 17,843 [62% of all patients with PD that year] to 22,282 [68%]), speech-language therapy (from 2171 [8%] to 3378 [10%]), and occupational therapy (from 2813 [10%] to 5939 [18%]). Among therapy-requiring patients, the percentage who were treated by a specialized therapist rose substantially for physiotherapy (from 36% in 2012 to 62% in 2017; χ2 = 2460.2; p < 0.001), speech-language therapy (from 59% to 85%; χ2 = 445.4; p < 0.001), and occupational therapy (from 61% to 77%; χ2 = 231.6; p < 0.001). By contrast, the number of patients with generic therapists did not change meaningfully. By 2017, specialized care delivery had extended to regions that had been poorly covered in 2012, essentially achieving nationwide coverage. CONCLUSIONS Following the publication of positive trials, specialized allied healthcare delivery was successfully scaled for patients with PD in the Netherlands, potentially serving as a template for other healthcare innovations for patients with PD elsewhere.
Collapse
Affiliation(s)
- Bastiaan R Bloem
- Department of Neurology, Cognition and Behaviour, Donders Institute for Brain, Radboud University Medical Centre, Nijmegen, the Netherlands
| | - Marietta Eimers
- Department of Neurology, Cognition and Behaviour, Donders Institute for Brain, Radboud University Medical Centre, Nijmegen, the Netherlands
| | | | - Marten Munneke
- Department of Neurology, Cognition and Behaviour, Donders Institute for Brain, Radboud University Medical Centre, Nijmegen, the Netherlands
| | - Sirwan K L Darweesh
- Department of Neurology, Cognition and Behaviour, Donders Institute for Brain, Radboud University Medical Centre, Nijmegen, the Netherlands.,Department of Epidemiology, Erasmus MC University Medical Centre, Rotterdam, the Netherlands
| |
Collapse
|
10
|
Loewenbrück KF, Stein DB, Amelung VE, Bitterlich R, Brumme M, Falkenburger B, Fehre A, Feige T, Frank A, Gißke C, Helmert C, Kerkemeyer L, Knapp A, Lang C, Leuner A, Lummer C, Minkman MMN, Müller G, van Munster M, Schlieter H, Themann P, Zonneveld N, Wolz M. Parkinson Network Eastern Saxony (PANOS): Reaching Consensus for a Regional Intersectoral Integrated Care Concept for Patients with Parkinson's Disease in the Region of Eastern Saxony, Germany. J Clin Med 2020; 9:E2906. [PMID: 32911841 PMCID: PMC7563971 DOI: 10.3390/jcm9092906] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Revised: 08/30/2020] [Accepted: 08/31/2020] [Indexed: 02/07/2023] Open
Abstract
As integrated care is recognized as crucial to meet the challenges of chronic conditions such as Parkinson's disease (PD), integrated care networks have emerged internationally and throughout Germany. One of these networks is the Parkinson Network Eastern Saxony (PANOS). PANOS aims to deliver timely and equal care to PD patients with a collaborative intersectoral structured care pathway. Additional components encompass personalized case management, an electronic health record, and communicative and educative measures. To reach an intersectoral consensus of the future collaboration in PANOS, a structured consensus process was conducted in three sequential workshops. Community-based physicians, PD specialists, therapists, scientists and representatives of regulatory authorities and statutory health insurances were asked to rate core pathway-elements and supporting technological, personal and communicative measures. For the majority of core elements/planned measures, a consensus was reached, defined as an agreement by >75% of participants. Additionally, six representatives from all partners involved in the network-design independently assessed PANOS based on the Development Model for Integrated Care (DMIC), a validated model addressing the comprehensiveness and maturity of integrated care concepts. The results show that PANOS is currently in an early maturation state but has the potential to comprehensively represent the DMIC if all planned activities are implemented successfully. Despite the favorable high level of consensus regarding the PANOS concept and despite its potential to become a balanced integrated care concept according to the DMIC, its full implementation remains a considerable challenge.
Collapse
Affiliation(s)
- Kai F. Loewenbrück
- Department of Neurology, University Hospital Dresden, 01307 Dresden, Germany; (R.B.); (B.F.); (T.F.); (A.F.)
- Clinical Trial Unit, German Center for Neurodegenerative Diseases (DZNE) Dresden, 01307 Dresden, Germany
| | - Doron B. Stein
- Institute for Applied Health Services Research (inav), Schiffbauerdamm 12, 10117 Berlin, Germany; (D.B.S.); (V.E.A.); (M.B.); (L.K.); (C.L.)
| | - Volker E. Amelung
- Institute for Applied Health Services Research (inav), Schiffbauerdamm 12, 10117 Berlin, Germany; (D.B.S.); (V.E.A.); (M.B.); (L.K.); (C.L.)
| | - Robert Bitterlich
- Department of Neurology, University Hospital Dresden, 01307 Dresden, Germany; (R.B.); (B.F.); (T.F.); (A.F.)
| | - Martin Brumme
- Institute for Applied Health Services Research (inav), Schiffbauerdamm 12, 10117 Berlin, Germany; (D.B.S.); (V.E.A.); (M.B.); (L.K.); (C.L.)
| | - Björn Falkenburger
- Department of Neurology, University Hospital Dresden, 01307 Dresden, Germany; (R.B.); (B.F.); (T.F.); (A.F.)
- Clinical Trial Unit, German Center for Neurodegenerative Diseases (DZNE) Dresden, 01307 Dresden, Germany
| | - Annekathrin Fehre
- Department of Neurology, Elblandklinikum Meißen, 01662 Meißen, Germany; (A.F.); (A.L.); (M.W.)
| | - Tim Feige
- Department of Neurology, University Hospital Dresden, 01307 Dresden, Germany; (R.B.); (B.F.); (T.F.); (A.F.)
| | - Anika Frank
- Department of Neurology, University Hospital Dresden, 01307 Dresden, Germany; (R.B.); (B.F.); (T.F.); (A.F.)
- Clinical Trial Unit, German Center for Neurodegenerative Diseases (DZNE) Dresden, 01307 Dresden, Germany
| | - Carola Gißke
- Chair of Business Informatics, esp. Systems Development, Faculty of Business and Economics, Technical University of Dresden, 01062 Dresden, Germany; (C.G.); (H.S.)
| | - Claudia Helmert
- Center for Evidence-based Healthcare, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany; (C.H.); (A.K.); (C.L.); (G.M.)
| | - Linda Kerkemeyer
- Institute for Applied Health Services Research (inav), Schiffbauerdamm 12, 10117 Berlin, Germany; (D.B.S.); (V.E.A.); (M.B.); (L.K.); (C.L.)
| | - Andreas Knapp
- Center for Evidence-based Healthcare, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany; (C.H.); (A.K.); (C.L.); (G.M.)
| | - Caroline Lang
- Center for Evidence-based Healthcare, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany; (C.H.); (A.K.); (C.L.); (G.M.)
| | - Annegret Leuner
- Department of Neurology, Elblandklinikum Meißen, 01662 Meißen, Germany; (A.F.); (A.L.); (M.W.)
| | - Carina Lummer
- Institute for Applied Health Services Research (inav), Schiffbauerdamm 12, 10117 Berlin, Germany; (D.B.S.); (V.E.A.); (M.B.); (L.K.); (C.L.)
| | - Mirella M. N. Minkman
- Vilans, National Centre of Expertise in Long Term Care, 3527 GV Utrecht, The Netherlands; (M.M.N.M.); (N.Z.)
- Tilburg University/TIAS School for Business and Society, 5037 AB Tilburg, The Netherlands
| | - Gabriele Müller
- Center for Evidence-based Healthcare, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany; (C.H.); (A.K.); (C.L.); (G.M.)
| | - Marlena van Munster
- Department of Neurology, University Hospital Marburg, 35043 Marburg, Germany;
| | - Hannes Schlieter
- Chair of Business Informatics, esp. Systems Development, Faculty of Business and Economics, Technical University of Dresden, 01062 Dresden, Germany; (C.G.); (H.S.)
| | - Peter Themann
- Department of Neurology, Klinik am Tharandter Wald Hetzdorf, Herzogswalder Straße 1, 09633 Halsbrücke, Germany;
| | - Nick Zonneveld
- Vilans, National Centre of Expertise in Long Term Care, 3527 GV Utrecht, The Netherlands; (M.M.N.M.); (N.Z.)
- Tilburg University/TIAS School for Business and Society, 5037 AB Tilburg, The Netherlands
| | - Martin Wolz
- Department of Neurology, Elblandklinikum Meißen, 01662 Meißen, Germany; (A.F.); (A.L.); (M.W.)
| |
Collapse
|
11
|
Connor KI, Siebens HC, Mittman BS, Ganz DA, Barry F, Ernst EJ, Edwards LK, McGowan MG, McNeese-Smith DK, Cheng EM, Vickrey BG. Quality and extent of implementation of a nurse-led care management intervention: care coordination for health promotion and activities in Parkinson's disease (CHAPS). BMC Health Serv Res 2020; 20:732. [PMID: 32778083 PMCID: PMC7418202 DOI: 10.1186/s12913-020-05594-8] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2019] [Accepted: 07/29/2020] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND A recent nurse-led, telephone-administered 18-month intervention, Care Coordination for Health Promotion and Activities in Parkinson's Disease (CHAPS), was tested in a randomized controlled trial and improved care quality. Therefore, intervention details on nurse care manager activity (types and frequencies) and participant actions are needed to support potential dissemination. Activities include nurse care manager use of a holistic organizing framework, identification of Parkinson's disease (PD)-related problems/topics, communication with PD specialists and care coordination, participant coaching, and participant self-care actions including use of a notebook self-care tool. METHODS This article reports descriptive data on the CHAPS intervention. The study setting was five sites in the Veterans Affairs Healthcare System. Sociodemographic data were gathered from surveys of study participants (community-dwelling veterans with PD). Nurse care manager intervention activities were abstracted from electronic medical records and logbooks. Statistical analysis software was used to provide summary statistics; closed card sorting was used to group some data. RESULTS Intervention participants (n = 140) were primarily men, mean age 69.4 years (standard deviation 10.3) and community-dwelling. All received the CHAPS Initial Assessment, which had algorithms designed to identify 31 unique CHAPS standard problems/topics. These were frequently documented (n = 4938), and 98.6% were grouped by assigned domain from the Organizing Framework (Siebens Domain Management Model™). Nurse care managers performed 27 unique activity types to address identified problems, collaborating with participants and PD specialists. The two most frequent unique activities were counseling/emotional support (n = 387) and medication management (n = 349). Both were among 2749 total performed activities in the category Implementing Interventions (coaching). Participants reported unique self-care action types (n = 23) including use of a new notebook self-care tool. CONCLUSIONS CHAPS nurse care managers implemented multiple activities including participant coaching and care coordination per the CHAPS protocol. Participants reported various self-care actions including use of a personalized notebook. These findings indicate good quality and extent of implementation, contribute to ensuring reproducibility, and support CHAPS dissemination as a real-world approach to improve care quality. TRIAL REGISTRATION ClinicalTrials.gov as NCT01532986 , registered on January 13, 2012.
Collapse
Affiliation(s)
- Karen I. Connor
- Veterans Affairs Southwest Parkinson’s Disease Research, Education and Clinical Center, Los Angeles, CA USA
- University of California, Los Angeles David Geffen School of Medicine, Los Angeles, CA USA
- Novato, USA
| | | | | | - David A. Ganz
- University of California, Los Angeles David Geffen School of Medicine, Los Angeles, CA USA
- Veterans Affairs Geriatric Research, Education and Clinical Center and Center for the Study of Healthcare Innovation, Implementation and Policy, Los Angeles, CA USA
| | - Frances Barry
- University of California, Los Angeles David Geffen School of Medicine, Los Angeles, CA USA
| | - E. J. Ernst
- American Association of Nurse Practitioners, Austin, TX USA
| | - Lisa K. Edwards
- Veterans Affairs Southwest Parkinson’s Disease Research, Education and Clinical Center, Los Angeles, CA USA
| | - Michael G. McGowan
- Veterans Affairs Southwest Parkinson’s Disease Research, Education and Clinical Center, Los Angeles, CA USA
| | | | - Eric M. Cheng
- University of California, Los Angeles David Geffen School of Medicine, Los Angeles, CA USA
| | | |
Collapse
|
12
|
Bloem BR, Rompen L, Vries NMD, Klink A, Munneke M, Jeurissen P. ParkinsonNet: A Low-Cost Health Care Innovation With A Systems Approach From The Netherlands. Health Aff (Millwood) 2018; 36:1987-1996. [PMID: 29137501 DOI: 10.1377/hlthaff.2017.0832] [Citation(s) in RCA: 66] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
ParkinsonNet, a low-cost innovation to optimize care for patients with Parkinson disease, was developed in 2004 as a network of physical therapists in several regions in the Netherlands. Since that time, the network has achieved full national reach, with 70 regional networks and around 3,000 specifically trained professionals from 12 disciplines. Key elements include the empowerment of professionals who are highly trained and specialized in Parkinson disease, the empowerment of patients by education and consultation, and the empowerment of integrated multidisciplinary teams to better address and manage the disease. Studies have found that the ParkinsonNet approach leads to outcomes that are at least as good as, if not better than, outcomes from usual care. One study found a 50 percent reduction in hip fractures and fewer inpatient admissions. Other studies suggest that ParkinsonNet leads to modest but important cost savings (at least US$439 per patient annually). These cost savings outweigh the costs of building and maintaining the network. Because of ParkinsonNet's success, the program has now spread to several other countries and serves as a model of a successful and scalable frugal innovation.
Collapse
Affiliation(s)
- Bas R Bloem
- Bas R. Bloem is a professor in the Department of Neurology, Radboud University Medical Centre, in Nijmegen, and medical director of ParkinsonNet, in the Netherlands
| | - Lonneke Rompen
- Lonneke Rompen is a policy adviser at the Department of Neurology, Radboud University Medical Centre
| | - Nienke M de Vries
- Nienke M. de Vries is a researcher in the Department of Neurology, Radboud University Medical Centre
| | - Ab Klink
- Ab Klink is on the Faculty of Social Sciences, Political Science, and Public Administration at Vrije Universiteit Amsterdam, in the Netherlands
| | - Marten Munneke
- Marten Munneke is an associate professor in the Department of Neurology and the Department of Rehabilitation and Allied Health, Radboud University Medical Centre
| | - Patrick Jeurissen
- Patrick Jeurissen ( ) is a professor in fiscal sustainable health care systems, Radboud University Medical School, and holds an affiliation with the Ministry of Health in the Netherlands
| |
Collapse
|
13
|
Patient-centered integrated healthcare improves quality of life in Parkinson's disease patients: a randomized controlled trial. J Neurol 2018; 265:764-773. [PMID: 29392459 DOI: 10.1007/s00415-018-8761-7] [Citation(s) in RCA: 47] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2017] [Revised: 01/15/2018] [Accepted: 01/19/2018] [Indexed: 10/18/2022]
Abstract
INTRODUCTION Improving quality of life (QoL) is a key issue when dealing with Parkinson's disease (PD). Integrative care shows potential to achieve improvements in QoL. Here, we analyzed whether a community-based, open-label, integrated approach improves QoL in PD patients. METHODS PD patients were screened for eligibility and evaluated by a university-based PD specialist, a PD nurse, and a general neurologist at a local practice. Patients were randomly assigned to a control group (CG), receiving standard German neurological treatment including a baseline assessment and follow-up visit at 6 months, or an interventional group (IG) who received an individually tailored therapy plan and additional home visits. Patients and investigators were not blinded for either intervention. Primary outcome analysis compared the differential change of PDQ-39 from baseline to 6-month follow-up between CG and IG. Between-group changes in mood, motor/non-motor functioning, and cognition were secondary outcomes. RESULTS 300 patients were included and randomized equally to IG and CG. 132 IG and 125 CG patients had a valid PDQ-39 at follow-up and qualified for the modified ITT analysis. PDQ-39 improved more in IG compared to CG [2.2 points (95% CI - 4.4 to 0.1); p = 0.044]. Likewise, change scores between IG and CG favored IG for UPDRS III (p < 0.001, mean change 3.3, 95% CI - 4.9 to - 1.7) and PD-NMS (p < 0.001, mean change 11.3, 95% CI - 17.1 to - 5.5). CONCLUSIONS Data show that an integrated approach, compared to regular PD care, improves QoL as well as motor and nonmotor PD symptoms over 6 months. Future studies need to address the cost-benefit ratio and whether positive effects can be maintained beyond intervention.
Collapse
|
14
|
Radder DL, Sturkenboom IH, van Nimwegen M, Keus SH, Bloem BR, de Vries NM. Physical therapy and occupational therapy in Parkinson's disease. Int J Neurosci 2017; 127:930-943. [DOI: 10.1080/00207454.2016.1275617] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Danique L.M. Radder
- Department of Neurology, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Ingrid H. Sturkenboom
- Department of Rehabilitation-Occupational Therapy, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Marlies van Nimwegen
- Department of Neurology, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Samyra H. Keus
- Department of Neurology, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Bastiaan R. Bloem
- Department of Neurology, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Nienke M. de Vries
- Department of Neurology, Radboud University Medical Center, Nijmegen, the Netherlands
| |
Collapse
|
15
|
Bhidayasiri R, Boonpang K, Jitkritsadakul O, Calne SM, Henriksen T, Trump S, Chaiwong S, Susang P, Boonrod N, Sringean J, van Laar T, Drent M, Chaudhuri KR. Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therpy. Parkinsonism Relat Disord 2016; 33 Suppl 1:S49-S55. [PMID: 27939324 DOI: 10.1016/j.parkreldis.2016.11.014] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/29/2016] [Revised: 11/20/2016] [Accepted: 11/22/2016] [Indexed: 10/20/2022]
Abstract
Optimal care of Parkinson's disease (PD) patients should involve a multidisciplinary team (MDT) of which a PD nurse specialist (PDNS) is a key member. The role of a PDNS is particularly prominent in the care of advanced PD patients suitable for apomorphine because, in addition to nursing skills, apomorphine treatment requires liaison, training, interaction and coordination with patients, caregivers and other members of the MDT as well as the interface with primary care physicians. The therapeutic success of apomorphine therapy depends not only upon the pharmacologic drug response, but also on how well the patient understands his/her disease and how to handle the therapy. In this respect, a PDNS is a vital member of the MDT who provides education and training, support, and is available for consultation when problems arise. In this article, we review the literature on the contribution of PDNSs in both continuous subcutaneous apomorphine infusion and intermittent subcutaneous apomorphine injection and highlight the various beneficial aspects of PDNS care, supported by scientific evidence when available. Despite a low level of published evidence, there is strong clinical evidence that the impact of PDNSs on the management of apomorphine therapy is vital and indispensable for the success of this treatment.
Collapse
Affiliation(s)
- Roongroj Bhidayasiri
- Chulalongkorn Center of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, 10330, Thailand; Department of Rehabilitation Medicine, Juntendo University, Tokyo, Japan.
| | - Kamolwan Boonpang
- Chulalongkorn Center of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, 10330, Thailand
| | - Onanong Jitkritsadakul
- Chulalongkorn Center of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, 10330, Thailand
| | - Susan M Calne
- Pacific Parkinson's Research Center, University of British Columbia, Vancouver, (1982-2007), Canada
| | - Tove Henriksen
- Movement Disorder Clinic, University Hospital of Bispebjerg, Copenhagen, Denmark
| | - Sally Trump
- National Parkinson Foundation Centre of Excellence, King's College Hospital, London, United Kingdom
| | - Suchapit Chaiwong
- Chulalongkorn Center of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, 10330, Thailand
| | - Phenprapa Susang
- Chulalongkorn Center of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, 10330, Thailand
| | - Nonglak Boonrod
- Chulalongkorn Center of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, 10330, Thailand
| | - Jirada Sringean
- Chulalongkorn Center of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, 10330, Thailand
| | - Teus van Laar
- Department of Neurology, University of Groningen, Groningen, The Netherlands
| | - Martje Drent
- Department of Neurology, University of Groningen, Groningen, The Netherlands
| | - K Ray Chaudhuri
- National Parkinson Foundation Centre of Excellence, King's College Hospital, London, United Kingdom
| |
Collapse
|